Literature DB >> 25449014

Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cells.

Hilal S Khalil1, Alexey Goltsov2, Simon P Langdon3, David J Harrison4, James Bown5, Yusuf Deeni6.   

Abstract

Cells are constantly exposed to Reactive Oxygen Species (ROS) produced both endogenously to meet physiological requirements and from exogenous sources. While endogenous ROS are considered as important signalling molecules, high uncontrollable ROS are detrimental. It is unclear how cells can achieve a balance between maintaining physiological redox homeostasis and robustly activate the antioxidant system to remove exogenous ROS. We have utilised a Systems Biology approach to understand how this robust adaptive system fulfils homeostatic requirements of maintaining steady-state ROS and growth rate, while undergoing rapid readjustment under challenged conditions. Using a panel of human ovarian and normal cell lines, we experimentally quantified and established interrelationships between key elements of ROS homeostasis. The basal levels of NRF2 and KEAP1 were cell line specific and maintained in tight correlation with their growth rates and ROS. Furthermore, perturbation of this balance triggered cell specific kinetics of NRF2 nuclear-cytoplasmic relocalisation and sequestration of exogenous ROS. Our experimental data were employed to parameterise a mathematical model of the NRF2 pathway that elucidated key response mechanisms of redox regulation and showed that the dynamics of NRF2-H2O2 regulation defines a relationship between half-life, total and nuclear NRF2 level and endogenous H2O2 that is cell line specific. Crown
Copyright © 2014. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mathematical modelling; NRF2 localisation; Oxidative stress; Proliferation; ROS

Mesh:

Substances:

Year:  2014        PMID: 25449014     DOI: 10.1016/j.jbiotec.2014.09.027

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  19 in total

1.  Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion.

Authors:  Monique G P van der Wijst; Christian Huisman; Archibold Mposhi; Gerard Roelfes; Marianne G Rots
Journal:  Mol Oncol       Date:  2015-03-19       Impact factor: 6.603

Review 2.  Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.

Authors:  Shengnan Liu; Jingbo Pi; Qiang Zhang
Journal:  Redox Biol       Date:  2022-06-30       Impact factor: 10.787

3.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

4.  A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells.

Authors:  Hilal S Khalil; Simon P Langdon; Alexey Goltsov; Tero Soininen; David J Harrison; James Bown; Yusuf Y Deeni
Journal:  Oncotarget       Date:  2016-11-15

5.  Developing a genetic signature to predict drug response in ovarian cancer.

Authors:  Stephen Hyter; Jeff Hirst; Harsh Pathak; Ziyan Y Pessetto; Devin C Koestler; Rama Raghavan; Dong Pei; Andrew K Godwin
Journal:  Oncotarget       Date:  2017-12-26

6.  Long Noncoding RNA DICER1-AS1 Functions in Methylation Regulation on the Multi-Drugresistance of Osteosarcoma Cells via miR-34a-5p and GADD45A.

Authors:  Feng Wang; Lingsuo Kong; Youguang Pu; Fengmei Chao; Chunbao Zang; Wei Qin; Fangfang Zhao; Shanbao Cai
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

7.  NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.

Authors:  Hilal S Khalil; Simon P Langdon; Ibrahim H Kankia; James Bown; Yusuf Y Deeni
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

8.  Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.

Authors:  Jianfa Wu; Lingjie Bao; Zhenbo Zhang; Xiaofang Yi
Journal:  Oncotarget       Date:  2017-07-25

9.  NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib.

Authors:  Ibrahim H Kankia; Hilal S Khalil; Simon P Langdon; Peter R Moult; James L Bown; Yusuf Y Deeni
Journal:  Oxid Med Cell Longev       Date:  2017-12-19       Impact factor: 6.543

10.  Flavonoid constituents of Dobera glabra leaves: amelioration impact against CCl4-induced changes in the genetic materials in male rats.

Authors:  Ahmed Elkhateeb; Rasha R Abdel Latif; Mona M Marzouk; Sameh R Hussein; Mona E S Kassem; Wagdy K B Khalil; Mohamed A El-Ansari
Journal:  Pharm Biol       Date:  2016-09-23       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.